H
Hep-Covid Investigators
Publications - 1
Citations - 268
Hep-Covid Investigators is an academic researcher. The author has contributed to research in topics: Internal medicine & Randomized controlled trial. The author has an hindex of 1, co-authored 1 publications receiving 8 citations.
Papers
More filters
Journal ArticleDOI
Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial.
Alex C. Spyropoulos,Alex C. Spyropoulos,Alex C. Spyropoulos,Mark Goldin,Mark Goldin,Dimitrios Giannis,Wassim Diab,Janice Wang,Janice Wang,Sameer Khanijo,Andrea Mignatti,Andrea Mignatti,Eugenia Gianos,Eugenia Gianos,Marc Cohen,Gulru Sharifova,Jeet Lund,Alfonso Tafur,Alfonso Tafur,Paul A. Lewis,Kevin P. Cohoon,Husneara Rahman,Cristina Sison,Cristina Sison,Martin Lesser,Martin Lesser,Kanta Ochani,Nirav Agrawal,Judith Hsia,Victoria E. Anderson,Marc P. Bonaca,Jonathan L. Halperin,Jeffrey I. Weitz,Hep-Covid Investigators +33 more
TL;DR: In this article, the authors evaluated the effects of therapeutic-dose low-molecular-weight heparin (LMWH) vs institutional standard prophylactic or intermediate-dose heparins for thromboprophylaxis in high-risk hospitalized patients with COVID-19.